EP0333912A3 - Method for the evaporation of a sample - Google Patents
Method for the evaporation of a sample Download PDFInfo
- Publication number
- EP0333912A3 EP0333912A3 EP88111565A EP88111565A EP0333912A3 EP 0333912 A3 EP0333912 A3 EP 0333912A3 EP 88111565 A EP88111565 A EP 88111565A EP 88111565 A EP88111565 A EP 88111565A EP 0333912 A3 EP0333912 A3 EP 0333912A3
- Authority
- EP
- European Patent Office
- Prior art keywords
- evaporation
- sample
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05H—PLASMA TECHNIQUE; PRODUCTION OF ACCELERATED ELECTRICALLY-CHARGED PARTICLES OR OF NEUTRONS; PRODUCTION OR ACCELERATION OF NEUTRAL MOLECULAR OR ATOMIC BEAMS
- H05H3/00—Production or acceleration of neutral particle beams, e.g. molecular or atomic beams
- H05H3/02—Molecular or atomic beam generation
Landscapes
- Physics & Mathematics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Engineering & Computer Science (AREA)
- Plasma & Fusion (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3809504A DE3809504C1 (en) | 1988-03-22 | 1988-03-22 | |
DE3809504 | 1988-03-22 |
Publications (3)
Publication Number | Publication Date |
---|---|
EP0333912A2 EP0333912A2 (en) | 1989-09-27 |
EP0333912A3 true EP0333912A3 (en) | 1990-03-07 |
EP0333912B1 EP0333912B1 (en) | 1995-06-28 |
Family
ID=6350311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP88111565A Expired - Lifetime EP0333912B1 (en) | 1988-03-22 | 1988-07-19 | Method for the evaporation of a sample |
Country Status (3)
Country | Link |
---|---|
US (1) | US5062935A (en) |
EP (1) | EP0333912B1 (en) |
DE (1) | DE3809504C1 (en) |
Families Citing this family (65)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4017805C2 (en) * | 1989-08-22 | 1998-03-26 | Finnigan Mat Gmbh | Method, preparation and device for providing an analyte for an examination |
DE4108462C2 (en) * | 1991-03-13 | 1994-10-13 | Bruker Franzen Analytik Gmbh | Method and device for generating ions from thermally unstable, non-volatile large molecules |
US6436635B1 (en) | 1992-11-06 | 2002-08-20 | Boston University | Solid phase sequencing of double-stranded nucleic acids |
US5605798A (en) | 1993-01-07 | 1997-02-25 | Sequenom, Inc. | DNA diagnostic based on mass spectrometry |
WO1994016101A2 (en) | 1993-01-07 | 1994-07-21 | Koester Hubert | Dna sequencing by mass spectrometry |
US6194144B1 (en) | 1993-01-07 | 2001-02-27 | Sequenom, Inc. | DNA sequencing by mass spectrometry |
ES2201077T3 (en) | 1993-05-28 | 2004-03-16 | Baylor College Of Medicine | METHOD AND SPECTROMETER OF MASSES FOR DESORTION AND IONIZATION OF ANALYTS. |
US6020208A (en) * | 1994-05-27 | 2000-02-01 | Baylor College Of Medicine | Systems for surface-enhanced affinity capture for desorption and detection of analytes |
US20020037517A1 (en) | 1993-05-28 | 2002-03-28 | Hutchens T. William | Methods for sequencing biopolymers |
EP0764264A2 (en) * | 1993-11-12 | 1997-03-26 | Waters Corporation | Enhanced resolution maldi tof-ms sample surface |
US6071610A (en) | 1993-11-12 | 2000-06-06 | Waters Investments Limited | Enhanced resolution matrix-laser desorption and ionization TOF-MS sample surface |
US7803529B1 (en) | 1995-04-11 | 2010-09-28 | Sequenom, Inc. | Solid phase sequencing of biopolymers |
US5830655A (en) | 1995-05-22 | 1998-11-03 | Sri International | Oligonucleotide sizing using cleavable primers |
US5589685A (en) * | 1995-05-26 | 1996-12-31 | Jen Wu; Kuang | Matrix enhanced SIMS |
US6146854A (en) * | 1995-08-31 | 2000-11-14 | Sequenom, Inc. | Filtration processes, kits and devices for isolating plasmids |
US5777324A (en) | 1996-09-19 | 1998-07-07 | Sequenom, Inc. | Method and apparatus for maldi analysis |
DE19782095T1 (en) | 1996-11-06 | 2000-03-23 | Sequenom Inc | DNA diagnosis based on mass spectrometry |
DK0937096T3 (en) | 1996-11-06 | 2004-06-14 | Sequenom Inc | Method of mass spectrometry analysis |
DE19705762C2 (en) * | 1997-02-14 | 2001-06-07 | Rainer Edmund Weinkauf | Method and device for generating gas jets |
US6207370B1 (en) | 1997-09-02 | 2001-03-27 | Sequenom, Inc. | Diagnostics based on mass spectrometric detection of translated target polypeptides |
US6723564B2 (en) | 1998-05-07 | 2004-04-20 | Sequenom, Inc. | IR MALDI mass spectrometry of nucleic acids using liquid matrices |
WO2001081829A1 (en) * | 2000-04-27 | 2001-11-01 | Brio Technology, Inc. | Method and apparatus for processing jobs on an enterprise-wide computer system |
US6756476B2 (en) | 2001-04-30 | 2004-06-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2021 daltons |
US6693080B2 (en) | 2001-04-30 | 2004-02-17 | Syn X Pharma | Biopolymer marker indicative of disease state having a molecular weight of 1521 daltons |
US6890763B2 (en) | 2001-04-30 | 2005-05-10 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1350 daltons |
US6593298B2 (en) | 2001-04-30 | 2003-07-15 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1690 daltons |
US7314717B2 (en) | 2001-04-30 | 2008-01-01 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons |
US6627608B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1206 daltons |
US6602855B2 (en) | 2001-04-30 | 2003-08-05 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1449 daltons |
US7294688B2 (en) | 2001-04-30 | 2007-11-13 | Nanogen Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons |
US6703366B2 (en) | 2001-04-30 | 2004-03-09 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1,896 daltons |
US7087435B2 (en) * | 2001-04-30 | 2006-08-08 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2753 daltons |
US6627607B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1845 daltons |
US20040198950A1 (en) * | 2001-04-30 | 2004-10-07 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 1518 daltons |
US6617308B2 (en) | 2001-04-30 | 2003-09-09 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1865 daltons |
US6599877B2 (en) | 2001-04-30 | 2003-07-29 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1020 daltons |
US6620786B2 (en) | 2001-04-30 | 2003-09-16 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having molecular weight of 2937 daltons |
US7049397B2 (en) * | 2001-04-30 | 2006-05-23 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1211 daltons |
US20020160533A1 (en) * | 2001-04-30 | 2002-10-31 | George Jackowski | Biopolymer marker indicative of disease state having a molecular of weight of 1525 daltons |
US20040224423A1 (en) * | 2001-04-30 | 2004-11-11 | George Jackowski | Biopolymer marker indicative of disease state having a molecular weight of 2056 daltons |
US6627606B2 (en) | 2001-04-30 | 2003-09-30 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 1465 daltons |
US7015004B2 (en) * | 2001-11-23 | 2006-03-21 | Syn X Pharma, Inc. | Inter-alpha trypsin inhibitor biopolymer marker indicative of insulin resistance |
US6620787B2 (en) | 2001-04-30 | 2003-09-16 | Syn X Pharma, Inc. | Biopolymer marker indicative of disease state having a molecular weight of 2267 daltons |
US6677303B2 (en) | 2001-04-30 | 2004-01-13 | Syn X Pharma | Biopolymer marker indicative of disease state having a molecular weight of 1097 daltons |
US7008800B2 (en) | 2001-04-30 | 2006-03-07 | Artemis Proteomics, Ltd. | Biopolymer marker indicative of disease state having a molecular weight of 1077 daltons |
US7132244B2 (en) * | 2001-11-21 | 2006-11-07 | Syn X Pharma, Inc. | Betaine/GABA transport protein biopolymer marker indicative of insulin resistance |
US7314762B2 (en) | 2001-11-21 | 2008-01-01 | Nanogen, Inc. | Apolipoprotein biopolymer markers indicative of insulin resistance |
US7179610B2 (en) * | 2001-11-23 | 2007-02-20 | Nanogen Inc. | Complement C3 precursor biopolymer markers indicative of insulin resistance |
US7094549B2 (en) * | 2001-11-23 | 2006-08-22 | Syn X Pharma, Inc. | Fibronectin biopolymer marker indicative of insulin resistance |
US20070003974A1 (en) * | 2001-11-23 | 2007-01-04 | George Jackowski | Cene-E biopolymer marker indicative of age matched control |
US7122327B2 (en) * | 2001-11-23 | 2006-10-17 | Nanogen Inc. | Biopolymer markers indicative of type II diabetes |
US7179606B2 (en) * | 2001-11-23 | 2007-02-20 | Syn X Pharma, Inc. | IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease |
WO2003046567A2 (en) * | 2001-11-23 | 2003-06-05 | Syn. X Pharma, Inc. | Protein biopolymer markers predictive of alzheimers disease |
US7125678B2 (en) * | 2001-11-23 | 2006-10-24 | Nanogen, Inc. | Protein biopolymer markers predictive of type II diabetes |
US7179605B2 (en) | 2001-11-23 | 2007-02-20 | Nanogen Inc. | Fibronectin precursor biopolymer markers indicative of alzheimer's disease |
US6890722B2 (en) | 2001-11-23 | 2005-05-10 | Syn X Pharma, Inc. | HP biopolymer markers predictive of insulin resistance |
US7026129B2 (en) * | 2001-11-23 | 2006-04-11 | Syn X Pharma, Inc. | IG lambda biopolymer markers predictive of Alzheimers disease |
US7135297B2 (en) | 2001-11-23 | 2006-11-14 | Nanogen Inc. | Protein biopolymer markers indicative of insulin resistance |
US7052849B2 (en) * | 2001-11-23 | 2006-05-30 | Syn X Pharma, Inc. | Protein biopolymer markers predictive of insulin resistance |
US7097989B2 (en) * | 2001-11-23 | 2006-08-29 | Syn X Pharma, Inc. | Complement C3 precursor biopolymer markers predictive of type II diabetes |
US7074576B2 (en) * | 2001-11-23 | 2006-07-11 | Syn X Pharma, Inc. | Protein biopolymer markers indicative of alzheimer's disease |
US20030113808A1 (en) * | 2001-12-13 | 2003-06-19 | George Jackowski | Apolipoprotein biopolymer markers predictive of alzheimers disease |
JP3530942B2 (en) * | 2002-03-05 | 2004-05-24 | 独立行政法人通信総合研究所 | Molecular beam generation method and apparatus |
EP2299267A3 (en) | 2005-11-16 | 2011-05-04 | Novartis AG | Biomarkers for anti-NogoA antibody treatment in spinal cord injury |
FR2995403B1 (en) * | 2012-09-13 | 2014-09-12 | Commissariat Energie Atomique | METHOD AND DEVICE FOR QUANTITATIVE MEASUREMENT BY LIBS OF BIOMOLECULAR TARGETS ON BIO-CHIP |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3018455A1 (en) * | 1979-05-16 | 1980-11-27 | Varian Mat Gmbh | Ionisation of organic samples on conveyor belt - which carries sample from liq. chromatographic appts. into mass spectrometer |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4091256A (en) * | 1975-01-16 | 1978-05-23 | The United States Of America As Represented By The Secretary Of The Air Force | Pulsed atomic beam apparatus |
US4091265A (en) * | 1975-08-06 | 1978-05-23 | Racor Industries, Inc. | Fuel filter heating assembly |
DE2654057B1 (en) * | 1976-11-29 | 1978-04-27 | Varian Mat Gmbh | Process for the ionization of organic substances, as well as analyzer using this process |
DE3224801C2 (en) * | 1982-07-02 | 1986-04-30 | Edward William Prof. Dr. 8000 München Schlag | Method and device for generating pulsed molecular beams containing large, thermally unstable molecules |
US4728796A (en) * | 1986-04-10 | 1988-03-01 | Medical College Of Wisconsin | Method for ionization of polymers |
-
1988
- 1988-03-22 DE DE3809504A patent/DE3809504C1/de not_active Expired
- 1988-07-19 EP EP88111565A patent/EP0333912B1/en not_active Expired - Lifetime
-
1989
- 1989-03-21 US US07/326,763 patent/US5062935A/en not_active Expired - Lifetime
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3018455A1 (en) * | 1979-05-16 | 1980-11-27 | Varian Mat Gmbh | Ionisation of organic samples on conveyor belt - which carries sample from liq. chromatographic appts. into mass spectrometer |
Non-Patent Citations (3)
Title |
---|
ANALYTICAL CHEMISTRY, Band 50, Nr. 7, 19. June 1978, Seiten 985-991, American Chemical Society, Columbus, Ohio, US; M.A. POSTHUMUS et al.: "Laser desorption-mass spectrometry of polar nonvolatile bio-organic molecules" * |
ANALYTICAL CHEMISTRY, Band 53, Nr. 1, Januar 1981, Seiten 109-113, American Chemical Society, Columbus, Ohio, US; L.K. LIU et al.: "Matrix-assisted secondary ion mass spectra of biological compounds" * |
TRAC (TRENDS IN ANALYTICAL CHEMISTRY), Band 6, Nr. 4, April 1987, Seiten 78-81, Elsevier Science Publishers B.V., Amsterdam, NL; R. ISOBE et al.: "Direct microanalysis by negative ion fast atom bombardment mass spectrometry" * |
Also Published As
Publication number | Publication date |
---|---|
DE3809504C1 (en) | 1989-09-21 |
US5062935A (en) | 1991-11-05 |
EP0333912A2 (en) | 1989-09-27 |
EP0333912B1 (en) | 1995-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0333912A3 (en) | Method for the evaporation of a sample | |
GB8814705D0 (en) | Method | |
GB8823671D0 (en) | Method for mixing vapour | |
YU34189A (en) | Process for obtaining antihipercholesterole tetrazolic compounds and their intermediers | |
GB8822145D0 (en) | Method | |
YU7189A (en) | Process for obtaining 1-alkyl-5-nitroimidazole | |
GB8827699D0 (en) | Sectional container & method for assembly thereof | |
YU85489A (en) | Process for obtaining l-alanyn | |
GB8827847D0 (en) | Method | |
GB8823765D0 (en) | Method & instrument | |
BG50834A3 (en) | Method for the preparation of 3- acyl- 2- oxindole- 1- carboxamides | |
GB8829942D0 (en) | Method | |
GB8800292D0 (en) | Assay method | |
IL89593A (en) | Target association method | |
EP0325248A3 (en) | A process for the chlorodephenylation of phenylsilanes | |
GB8802484D0 (en) | Process | |
YU36489A (en) | Process for obtaining polyestheralcohole | |
GB8810354D0 (en) | Method | |
GB8908404D0 (en) | A method of storing urine sample | |
GR900100777A (en) | Improved method for useful diazinylpiperidines | |
YU204889A (en) | Process for obtaining dinytrotoluol | |
GB9200682D0 (en) | Noncorruptible read-writer method | |
GB8800312D0 (en) | Process | |
BG46202A1 (en) | Method for obtaining alpha- dialuminia trioxide | |
GB8814904D0 (en) | Roofing materials & method for roofing |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
PUAL | Search report despatched |
Free format text: ORIGINAL CODE: 0009013 |
|
AK | Designated contracting states |
Kind code of ref document: A3 Designated state(s): AT BE CH DE ES FR GB GR IT LI LU NL SE |
|
17P | Request for examination filed |
Effective date: 19900313 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): CH DE FR GB IT LI |
|
17Q | First examination report despatched |
Effective date: 19931014 |
|
RBV | Designated contracting states (corrected) |
Designated state(s): CH FR GB IT LI |
|
REG | Reference to a national code |
Ref country code: DE Ref legal event code: 8566 |
|
GRAA | (expected) grant |
Free format text: ORIGINAL CODE: 0009210 |
|
AK | Designated contracting states |
Kind code of ref document: B1 Designated state(s): CH FR GB IT LI |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: IT Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRE;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.SCRIBED TIME-LIMIT Effective date: 19950628 |
|
GBT | Gb: translation of ep patent filed (gb section 77(6)(a)/1977) |
Effective date: 19950629 |
|
ET | Fr: translation filed | ||
PLBE | No opposition filed within time limit |
Free format text: ORIGINAL CODE: 0009261 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT |
|
26N | No opposition filed | ||
REG | Reference to a national code |
Ref country code: GB Ref legal event code: IF02 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: GB Payment date: 20070718 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: CH Payment date: 20071002 Year of fee payment: 20 |
|
PGFP | Annual fee paid to national office [announced via postgrant information from national office to epo] |
Ref country code: FR Payment date: 20070712 Year of fee payment: 20 |
|
REG | Reference to a national code |
Ref country code: CH Ref legal event code: PL |
|
REG | Reference to a national code |
Ref country code: GB Ref legal event code: PE20 Expiry date: 20080718 |
|
PG25 | Lapsed in a contracting state [announced via postgrant information from national office to epo] |
Ref country code: GB Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION Effective date: 20080718 |